- Home
- LVWR vs CVAC Comparison
LVWR vs CVAC Comparison
Compare LVWR & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LVWR | CVAC |
|---|---|---|
| Founded | 2022 | 2000 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 977.1M | 1.1B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | LVWR | CVAC |
|---|---|---|
| Price | $4.58 | $4.32 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.83 |
| AVG Volume (30 Days) | 60.3K | ★ 1.7M |
| Earning Date | 02-04-2026 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 94.02 |
| EPS | N/A | ★ 0.94 |
| Revenue | $25,078,000.00 | ★ $83,000,117.00 |
| Revenue This Year | $249.13 | N/A |
| Revenue Next Year | $98.53 | $23.71 |
| P/E Ratio | ★ N/A | $4.59 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.93 | $2.48 |
| 52 Week High | $9.04 | $5.72 |
Technical Indicators
Market Signals| Indicator | LVWR | CVAC |
|---|---|---|
| Relative Strength Index (RSI) | 49.22 | 31.39 |
| Support Level | $4.45 | $4.00 |
| Resistance Level | $4.96 | $4.36 |
| Average True Range (ATR) | 0.29 | 0.16 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 49.51 | 22.51 |
Price Performance
Historical ComparisonAbout LVWR LiveWire Group Inc.
LiveWire Group Inc is an all-electric vehicle company. It sells electric vehicles and related parts and accessories and apparel in the United States and certain international markets. The company's segment includes Electric Motorcycles and STACYC. Electric Motorcycles segment sells electric motorcycles, related parts and accessories and apparel in the United States and certain international markets; STACYC segment sells electric balance bikes for kids, related parts and accessories and apparel in the United States and certain international markets. LiveWire generates revenue from the sale of electric motorcycles, Parts, accessories and apparel. Majority of revenue is from USA.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.